AUCTORES
Globalize your Research
Research Article
*Corresponding Author: Cindy Díaz, Unit, Endovascular Therapy Fellowship, Universidad Nacional Autonoma de Mexico, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco (INNN)
Citation: Cindy Díaz, Alfredo Montenegro, Jorge Balderrama, Alba Herrera (2021). Intracranial Atherosclerotic Stenosis: An Up-to-Date Review. J. Neuroscience and Neurological Surgery. 9(5); DOI:10.31579/2578-8868/214
Copyright: © 2021 Cindy Díaz, This is an open-access article distributed under the terms of The Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Received: 19 October 2021 | Accepted: 01 November 2021 | Published: 08 November 2021
Keywords: intracranial atherosclerotic stenosis; cerebrovascular accident; ischemic stroke
In this review, we discuss recent clinical assays that have contributed to understanding the disease process associated with ICAD, risk factors associated with CVA recurrence in this subgroup of patients, imaging characteristics related to the prognosis, and an update on the treatments that reduce CVA recurrence.
ICAD: intracranial atherosclerotic disease
CVA: cerebrovascular accident
IS: ischemic stroke
TIA: transient ischemic attack
TCD: transcranial doppler
MCA: middle cerebral artery
MRA: magnetic resonance angiography
A-ICAS: asymptomatic intracranial atherosclerotic stenosis
S-ICAS: symptomatic intracranial atherosclerotic stenosis
CTA: computerized tomography angiography
DSA: digital subtraction angiography
HRMRI: high-resolution magnetic resonance imaging
ICA: internal carotid artery
AMT: aggressive medical treatment
PTAS: percutaneous transluminal angioplasty and stenting
PTA: percutaneous transluminal angioplasty
ICH: intracerebral hemorrhage
ACA: anterior cerebral artery
PCA: posterior cerebral artery
EICS: elective intracranial stenting
Cerebrovascular accidents (CVA) or strokes are one of the main mortality and morbidity causes around the world. Large-vessel atherosclerosis represents 20% of ischemic strokes (IS), 50% are intracranial, and it is associated with a high risk of recurrent CVA compared with other CVA subtypes, despite even the best medical care [1]. Intracranial atherosclerotic disease (ICAD) is one of the main causes of IS, representing almost 5-10% of intracranial atherosclerotic strokes in the USA, and up to 50% in Asia [2].
Materials and Methods
A search was made in the databases of PubMed (http: //www.ncbi.nlm.nih. Gov / PubMed / medline.html), OVID (http://www.ovid.com/), Ebsco (http : //www.ebsco.com) with the following terms: intracranial atherosclerotic disease, ischemic stroke, symptomatic intracranial atherosclerotic stenosis, medical treatment, endovascular treatment
Epidemiology
ICAD causes between 5 and 10% of IS in white people, between 20 and 30% of transient ischemic attacks (TIA) or CVA in black people, and up to 30 to 50% of CVA in Asian people (3)(4). From a total of 900,000 CVA or TIA that occur each year in the USA, approximately 70,000-90,000 are caused by intracranial atherosclerotic stenosis [3,5]. The risk of recurrent CVA in these patients could be as high as 15% per year [6,7], and on other studies in patients with high-grade S-ICAD (stenosis: 70-99%), up to 23% per year despite aggressive antithrombotic therapy and standard vascular risk factor management [8,9]. Due to this elevated recurrence rate, there are alternative therapeutic options for the prevention of recurrent CVA in patients with severe ICAD that do not respond to medical treatments such as balloon angioplasty or stent placement [9,10].
Risk Factors
Symptomatic and asymptomatic ICAD risk factors include:
-Age
-Race: Afro American, Hispanic, and Asian compared to white people. [4,11].
-Cardiovascular risk pathologies:
*High blood pressure: In the Warfarin Aspirin Symptomatic Intracranial Disease (WASID) study, the most important modifiable risk factor that increases the risk of recurrent CVA and cardiovascular events (acute myocardial infarction and vascular death) associated with ICAD is high blood pressure (Systolic arterial pressure ≥ 140 mm Hg, HR= 1.79, p = 0.0009) [12].
*Diabetes Mellitus: High levels of A1C hemoglobin are not correlated to the severity of the ICAD, but diabetes mellitus remains as an independent risk factor [13].
*Hyperlipidemia: Those that are associated to a higher risk of recurrent CVA and ICAD progression are: total cholesterol serum levels ≥ 200 mg/dl (WASID study: Warfarin Aspirin Symptomatic Intracranial Disease, HR= 1.44, p = 0.048) (5)(12), increase in the apolipoprotein B (apoB)/apolipoprotein A-I (apoAI) rate (TOSS-2 study: Trial of cilOstazol in Symptomatic intracranial Stenosis 2), decrease in serum levels of high-density lipoprotein cholesterol- HDL [14].
*Metabolic syndrome [15,16].
-Sedentary lifestyle and diet [17]
-Smoking [18].
-Morphological characteristics of the stenosis: The risk of CVA in the territory of the stenotic artery was higher in severe stenosis ≥ 70% (HR= 2.03, p = 0.0025) [19].
-Collateral circulation: The presence of good collaterality in patients with stenosis ≥ 70
Diagnostic tools used to identify ICAD include:
Non-invasive methods:
- Transcranial Doppler (TCD): It is superior when providing flow information in real time and evidencing the direction of flow, collaterality, embolization (microembolic signs are an independent predictor of recurrence of CVA in patients with S-ICAD), and steal phenomenon, compared with static CT and MRA images [31]. It is useful for the standardized exploration protocol of Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) criteria to identify stenosis ≥ 50% stenosis. The optimal combined criteria for stenosis ≥ 70% were MCA average velocity >120 cm/s, or a stenosis/pre-stenosis ratio ≥3, or average-low velocity. In vertebral artery/basilar artery it varies >110 cm/s or stenotic/prestenotic ratio ≥ 3 [32].
- Magnetic resonance angiography (MRA): TOF-MRA is a flow sequence, accentuating hemodynamic characteristics and, as such, it generally overestimates the grade of stenosis, especially in cases with low distal flow to the ICAD location. The advantage of this sequence is that it makes it possible to evaluate the hemodynamic impact of the lesion [33].
Measurement techniques like the WASID Measurement Technique have been developed. Two measurements for each intracranial ACI are taken: 1) a linear measurement at the location of the most severe stenosis in the images either the MIP or axial source images; and 2) a linear measurement of the widest normal, non-tortuous portion of the petrous ACI parallel to the location of the stenosis. Using these measurements, we calculated the WASID grade of stenosis using the following equation (Figure 1): Percentage of stenosis = [(1 - [D stenosis / D normal])] x 100, where D stenosis is the diameter of the artery at the location with the most severe grade of stenosis and D normal is the diameter of the proximal artery in its widest, non-tortuous normal segment [34].
Computerized tomography angiography (CTA): It provides a better delimitation of the anatomy of intracranial arteries, which allows for higher diagnostic precision of luminar stenosis in ICAD compared to the TCD and MRA, with a sensitivity >95% in the diagnosis of ICAD (35) using DSA as the reference standard, even though the visualization of petrous and the cavernous segments of the internal carotid artery (ICA) by CTA could be affected by bone artifacts. Recently, CTA has been used more and more to evaluate collaterality in ICAD, including the leptomeningeal collaterals, which have been correlated to the risk or recurrent events, and recurrent CVA rates have been reported in patients with high grade stenosis (70-99%) of none vs good collaterality: HR= 4.60, and poor vs good collaterality: HR= 5.90 [3637]. Consequently, collateral flow is one of the most essential mediators in cerebral ischemia due to ICAD, making it an important indicator in the prediction of risk and the assignment of treatment in patients with symptomatic ICAD.
The anterograde and collateral blood flow (AnCo) scoring system is useful as a score to predict the state of anterograde and collateral blood flow in patients with S-ICAD of the MCA. The AnCo scoring system consists of the anterograde score (AnS) and the collateral score (CoS) [38].
Bash et al, after analyzing 115 sick vessels, found that CTA has higher sensitivity than MRA to detect ICAD (98% vs 70%, p <0>
-High-resolution magnetic resonance (HRMRI): It help in the assessment of the morphology of the intracranial plaque and the adjacent arterial wall, revealing the morphology and components of the plaque, including intraplaque, lipidic nucleus, and fibrous layer hemorrhage [37].
-Perfusion images (PerfuMRI or PerfuCT): this imaging modality makes it possible to identify potentially recoverable tissue or ischemic penumbra, so that they could be used to quantify the real collateral flow in the context of ICAD [40].
Invasive methods:
-Digital subtraction angiography (DSA): It is currently considered as the reference standard for the diagnosis of intracranial vascular diseases, including ICAD, because of its excellent spatial and contrast resolution to represent the vessels, and its capability to reveal temporal information about anterograde and collateral flow. A disadvantage as an invasive method is that it may lead to complications during the procedure, with rates of 1:1000 general neurological complications being reported (close to 2% in patients with ICAD) [33]. Therefore, DSA should not be routinely used to diagnose ICAD.
A challenge posed by these diagnostic tests is their limited capability to differentiate between an atherosclerotic plaque and other pathologies such as partially occlusive thrombus, vasospasm, vasculitis, or even preocclusive Moyamoya disease. Lately, high-resolution images of the vessel wall have been used to identify substenotic but active atherosclerotic plaques. In patients with ICAD, eccentric arterial thickening, and fibrous cap thickening in the image of the vessel wall could favor atherosclerosis of the thrombus or vasculitis [41].
The SONIA (Stroke Outcomes and Neuroimaging of Intracranial Atheroclerosis) study assessed the precision TCD and MRA compared to DSA, and it concluded that both have high negative predictive values (86 and 91%, respectively), but low positive predictive values (36 and 59%, respectively). Both techniques identify 50 to 99% of stenoses of large intracranial vessels non-invasively with substantial negative predictive value. This means that TCD and MRA are efficient for the exclusion of ICAD, but are less useful to establish a diagnosis of ICAD and to estimate the severity of the stenosis. Additionally, abnormal findings in TCD and MRA require a confirmation test, such as DSA, to reliably identify stenosis [31].
DSA is the diagnostic test that more precisely measures the grade or percentage of intracranial stenosis, above non-invasive tests. In conclusion, DSA is the gold standard for diagnosis and quantification of luminal stenosis of intracranial circulation, which is an independent predictor of recurrent CVA in the context of ICAD [41]. However, the grade of stenosis is not the only determining factor. Other factors are collateral circulation (hemodynamic impact), and morphological characteristics of the atherosclerotic plaque (plaque components) [33].
There are three types of treatment for ICAD: Medical, endovascular, and surgical treatment.
Medical treatment
In 1995, Chimowitz et al (Warfarin-Aspirin Symptomatic Intracranial Disease Study Group: WASID) published the multicentric and retrospective study: the “Warfarin-Aspirin Symptomatic Intracranial Disease Study”, to compare the efficacy of warfarin vs aspirin in the prevention of major vascular events (CVA, AMI or sudden death) in patients with S-ICAD. Seven centers and 151 patients participated; 88 were treated with warfarin and 63 with aspirin. The follow-up median was 14.7 months (warfarin group), and 19.3 months (aspirin group). Kaplan-Meier analysis showed a significantly higher percentage of patients free of major vascular events among patients treated with warfarin (p = 0,01). The relative risk of an important vascular event for these patients was 0.46 (95%CI: 0.23-0.86) as opposed to patients treated with aspirin. Important hemorrhagic complications occurred in three patients treated with warfarin (including two deaths) in 166 patients-year of follow-up, and none in the patients treated with aspirin in 143 patients-year of follow-up. This study suggests a favorable risk-benefit relation for warfarin, compared to aspirin for the prevention of major CVA in patients with S-ICAD [43]. This resulted in anticoagulation being informed for the first time as treatment for S-ICAD. Figure 2.
Later on in 2005, Chimowitz et al (Warfarin-Aspirin Symptomatic Intracranial Disease Study Group: WASID) published the multicentric blind clinical trial: “Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis”, where they randomized patients with these inclusion criteria: age ≥ 40 years, non-incapacitating TIA or CVA occurring 90 days before randomization, and which was attributable to a 50-99% stenosis verified by DSA in a main intracranial artery, a modified Rankin score ≤ 3, in two groups: warfarin 5 mg per day (INR objective 2.0-3.0) vs aspirin (total dosis per day: 1300 mg, 650 mg every 12 hours). In total, 569 patients were randomized, the study was stopped because of the worry regarding the safety profile of the arm of patients assigned to warfarin. During an average follow-up period of 1.8 years. The death ratio due to vascular causes was 3.2% aspirin vs 5.9% warfarin (p = 0.16); the death ratio due to non-vascular causes was 1.1% vs 3.8%, respectively (p = 0.05). In conclusion, warfarin was associated with significantly higher rates of adverse effects and did not provide any benefits compared to aspirin in this study. Aspirin should be preferably used instead of warfarin in patients with ICAD. A subanalysis was performed in the following contexts: severe stenosis (70-99%), vertebrobasilar stenosis or CVA symptoms in patients with antithrombotic treatment (therapeutic failure or failure in the response), who were previously thought to be benefitting from anticoagulation therapy. However, the WASID study findings showed that none of these subgroups have a significant benefit with warfarin [5].
In 2009, Turan et al published “Failure of Antithrombotic Therapy and Risk of Stroke in Patients With Symptomatic Intracranial Stenosis”, where they compared CVA or vascular death rates in ON vs OFF patients (patients in antithrombotic treatment or warfarin at the time when the index event occurred to be included in the WASID study vs patients without treatment). Concluding, patients with S-ICAD who fail in antithrombotic therapy do not have a higher risk of CVA than those that do not fail with this therapy. Given the fact that patients with antithrombotic treatment ON and OFF have a higher risk of CVA in the territory, the intracranial stent placement assays should not be limited to only those who fail in this therapy [44].
In 2012, Xin Wang et al, published “The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: a subgroup analysis of CLAIR study”, where they carried out an analysis of subgroups of the CLAIR study in patients with CVA or TIA with ICAD and microembolic signs confirmed with TCD recorded on days 1, 2, and 7. They included patients during the first seven days after the onset of symptoms, randomizing in two groups: group 1, clopidogrel (day 1: 300 mg and subsequently 75 mg/day plus aspirin (75-160 mg/day) for seven days (dual treatment), or just aspirin (75-160 mg/day) for seven days (monotherapy). They included 70 patients, 34 in the dual treatment dual and 36 in the monotherapy group. To conclude, dual treatment with clopidogrel and aspirin for seven days is more effective than only aspirin for reducing microembolic signs in patients with S-ICAD [45].
In 2012, the “Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis, SAMMPRIS Trial Investigators” was published, supporting the use of dual antithrombotic in the short term with aspirin and clopidogrel, followed by just aspirin. In this study they compared the aggressive medical treatment (AMT) vs percutaneous transluminal angioplasty and stenting (PTAS) to prevent recurrent CVA. The AMT in the SAMMPRIS study included:
-Dual antithrombotic therapy: aspirin 325 mg/day + clopidogrel 75 mg/day for 90 days after enrollment and subsequently, aspirin 325 mg/day during the rest of the assay.
-Control of primary risk factors: blood pressure <140>
-Control of secondary risk factors: diabetes mellitus, elevated non-high-density lipoprotein (non-HDL) cholesterol, smoking, obesity, and sedentarism aided by a lifestyle modification program.
The common practice of keeping blood pressure slightly high in patients with S-ICAD to reduce the risk of CVA by distal hypoperfusion, and increasing the systolic arterial pressure during follow-up in WASID did not reduce the risk of CVA in the stenotic artery territory, but in fact it increased the risk of recurrent CVA.
Patients who had had a recent (30 days) TIA or CVA attributed to 70-99% stenosis of the diameter of a major intracranial artery with AMT or AMT plus PTAS with a Wingspan stent were randomly assigned. The primary outcome was CVA or death within the following 30 days after enrollment or after a revascularization procedure for the qualifying lesion during the follow-up period or the CVA in the territory of the qualifying artery after the 30 days. The study stopped at the beginning of 2011, regardless of the fact that follow-up will finish in 2013. In total, 451 were randomized, because the rate of CVA or death at 30 days was 14.7% in the PTAS group (12.5% non-fatal CVA and 2.2
In summary, substantial progress in the treatment of patients with ICAS has been achieved in the past decade, which has led to better prognosis for patients with this high-risk disease. Multidisciplinary medical treatment that incorporates short-term dual antiplaque treatment (for 90 days), followed by monotherapy with aspirin, together with intensive treatment of vascular risk factors, is the preferred treatment for CVA prevention in these patients. In spite of this aggressive medical treatment, a large subgroup of patients still have a high risk of recurrent CVA. For them, the advancement of endovascular therapy devices are offering better effectiveness and safety rates, which explains the frequent reporting of successful treatment studies with stenting.
None
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
